LBF20107PG04: Difference between revisions
No edit summary |
No edit summary |
||
(15 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{Lipid/Header}} | |||
{{Hierarchy|{{PAGENAME}}}} | {{Hierarchy|{{PAGENAME}}}} | ||
Line 4: | Line 6: | ||
|LipidBank=XPR1709 | |LipidBank=XPR1709 | ||
|LipidMaps=LMFA03010146 | |LipidMaps=LMFA03010146 | ||
|SysName=9,15- | |SysName=9,15-Dioxo-11alpha-hydroxy-prost-trans-13-en-1-oic acid | ||
|Common Name=&&15-keto Prostaglandin E_1&&9,15- | |Common Name=&&15-keto Prostaglandin E_1&&9,15-Dioxo-11alpha-hydroxy-prost-13(E)-en-1-oic acid&& | ||
|Source=15-keto PGE1 is the inactive metabolite of PGE1 via PG15-dehydrogenase | |||
|Chemical Synthesis= | |||
|Metabolism= | |||
|Biological Activity=15-keto PGE1 has very slight biological activity compared to PGE1.[[Reference:Westwick_J:,Br. J. Pharmacol.,1976,58,297P|{{RelationTable/GetFirstAuthor|Reference:Westwick_J:,Br. J. Pharmacol.,1976,58,297P}}]] | |||
}} | }} | ||
{{Lipid/Footer}} |
Latest revision as of 17:01, 21 October 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1709 |
LipidMaps | LMFA03010146 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20107PG04 |
15-keto Prostaglandin E1 | |
---|---|
Structural Information | |
9,15-Dioxo-11α-hydroxy-prost-trans-13-en-1-oic acid | |
| |
Formula | C20H32O5 |
Exact Mass | 352.224974134 |
Average Mass | 352.46508 |
SMILES | C(CCC(=O)C=C[C@H]([C@H]1CCCCCCC(O)=O)[C@@H](CC1=O)O)CC |
Physicochemical Information | |
15-keto PGE1 is the inactive metabolite of PGE1 via PG15-dehydrogenase | |
15-keto PGE1 has very slight biological activity compared to PGE1. Westwick_J | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|